SARS-CoV-2 ORF3a 蛋白质作为针对COVID-19和长期感染后影响的治疗点
Jiantao Zhang1, Kellie Hom2, Chenyu Zhang1
1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Pathogens (Basel, Switzerland)
|January 22, 2024
概括
SARS-CoV-2的ORF3a蛋白质通过帮助病毒复制和炎症来驱动COVID-19的严重程度. 针对ORF3a提供了一个有前途的战略,用于开发新的抗病毒药物来治疗COVID-19及其并发症.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 由SARS-CoV-2引起的COVID-19由于病毒突变和疫苗/抗病毒疗效的减弱,提出了持续的挑战.
- 在SARS-CoV-2ORF3a蛋白对于病毒病原,免疫抑制和疾病严重程度至关重要.
- 通过NLRP3炎症酶激活和NF-κB信号传递,ORF3a有助于细胞因子风暴,导致器官损伤.
研究的目的:
- 探索SARS-CoV-2ORF3a蛋白作为一种新型抗病毒药物点的潜力.
- 审查ORF3a在COVID-19病变发生过程中的多方面的作用,包括病毒复制和宿主免疫反应.
- 讨论开发ORF3a抑制剂的策略,以减轻COVID-19的严重程度和长期并发症.
主要方法:
- 关于SARS-CoV-2 ORF3a蛋白的文献综述和科学研究分析.
- 检查ORF3a在病毒聚集,释放和免疫逃避中的作用.
- 调查ORF3a在炎症途径中的参与,包括NF-κB和NLRP3炎症酶激活.
主要成果:
- ORF3a促进SARS-CoV-2的复制和释放,同时抑制宿主抗病毒反应.
- ORF3a促进过度炎症和细胞因子风暴,导致肺,和中枢神经系统受损.
- 在ORF3a的突变可以与增加COVID-19的严重程度和改变宿主炎症反应相关.
结论:
- SARS-CoV-2 ORF3a 蛋白质是 COVID-19 病原和严重性的重要贡献者.
- 准ORF3a为开发创新的抗病毒疗法提供了一个有希望的途径.
- 开发ORF3a抑制剂可以帮助减少疾病的严重程度,组织损伤和COVID-19后的并发症.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K


